The PSA test is currently used to identify men at higher risk of prostate cancer due to age, ethnicity, or symptoms. However, it falsely indicates prostate cancer in men three out of four times and ...

Patients with advanced skin cancer in England are set to benefit from a revolutionary new cancer vaccine trial, thanks to the ex ...

Health and Social Care Secretary, Wes Streeting, has announced a comprehensive support package aimed at tackling violence and ...

Cancer trials dominate, making up nearly a third of all studies, while other major diseases, such as heart disease, receive ...

Grace, 36, from the south of England, was born without a functioning womb, preventing her from carrying and giving birth to ...

In a groundbreaking development, researchers in Manchester have successfully implemented a new test to identify patients in ...

Over the past decade, NICE has made nearly 100 positive recommendations, significantly advancing the treatment landscape for ...

The National Institute for Health and Care Research (NIHR) has announced a £24 million investment in five innovative Workforce R ...

Last week, the Medicines and Healthcare products Regulatory Agency hosted a landmark event in Westminster, London, to ...

This new framework agreement represents a significant step towards modernising NHS hardware, improving efficiency, and ...